Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains

Behavioral and Brain Functions

Volumn 1, Issue , 2005, Pages

  Mill, Jonathan ^a,b   Sagvolden, Terje ^c   Asherson, Philip ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1;

ARTICLE; ATTENTION DEFICIT DISORDER; CHROMOSOME 11Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 5P; CHROMOSOME 8Q; CONTROLLED STUDY; DEPRESSION; DNA SEQUENCE; DOPAMINERGIC TRANSMISSION; GENE LOCATION; GENETIC VARIABILITY; HUMAN; HYPERACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE;

EID: 33751001560     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-1-24     Document Type: Article

References (21)

1. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P: Molecular Genetics of Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry 57(11):1313-23. 6-1-2005
2. Russell VA, Sagvolden T, Johansen EB: Animal Models of Attention-Deficit Hyperactivity Disorder. Behav Brain Funct 1:9. 7-15-2005
3. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M: Rodent Models of Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry 57(11):1239-47. 6-1-2005
4. Sagvolden T: Behavioral Validation of the Spontaneously Hypertensive Rat (SHR) As an Animal Model of Attention-Deficit/Hyperactivity Disorder (AD/ HD). Neurosci Biobehav Rev 2000, 24(1):31-9.
5. Sagvolden T, Metzger MA, Schiorbeck HK, Rugland AL, Spinnangr I, Sagvolden G: The Spontaneously Hypertensive Rat (SHR) As an Animal Model of Childhood Hyperactivity (ADHD): Changed Reactivity to Reinforcers; and to Psychomotor Stimulants. Behav Neural Biol 1992, 58(2):103-12.
6. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J: Differences Between Electrically-, Ritalin- and D-Amphetamine-Stimulated Release of [3H]Dopamine From Brain Slices Suggest Impaired Vesicular Storage of Dopamine in an Animal Model of Attention-Deficit Hyperactivity Disorder. Behav Brain Res 1998, 94(1):163-71.
7. Russell VA: Dopamine Hypofunction Possibly Results From a Defect in Glutamate-Stimulated Release of Dopamine in the Nucleus Accumbens Shell of a Rat Model for Attention Deficit Hyperactivity Disorder - the Spontaneously Hypertensive Rat. Neurosci Biobehav Rev 2003, 27(7):671-82.
8. Okamoto K, Aoki K: Development of a Strain of Spontaneously Hypertensive Rats. Jpn Circ J 1963, 27:282-93.
9. Huezo-Diaz P, Tandon K, Aitchison KJ: The Genetics of Depression and Related Traits. Curr Psychiatry Rep 2005, 7(2):117-24.
10. Dailly E, Chenu F, Renard CE, Bourin M: Dopamine, Depression and Antidepressants. Fundam Clin Pharmacol 2004, 18(6):601-7.
11. Lahmame A, del Arco C, Pazos A, Yritia M, Armario A: Are Wistar-Kyoto Rats a Genetic Animal Model of Depression Resistant to Antidepressants? Eur J Pharmacol 337(2-3):115-23. 10-22-1997
12. De La, Garza R, Mahoney JJ III: A Distinct Neurochemical Profile in WKY Rats at Baseline and in Response to Acute Stress: Implications for Animal Models of Anxiety and Depression. Brain Res 1021(2):209-18. 9-24-2004
13. Will CC, Aird F, Redei EE: Selectively Bred Wistar-Kyoto Rats: an Animal Model of Depression and Hyper-Responsiveness to Antidepressants. Mol Psychiatry 2003, 8(11):925-32.
14. Jiao X, Pare WP, Tejani-Butt S: Strain Differences in the Distribution of Dopamine Transporter Sites in Rat Brain. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27(6):913-9.
15. Jeanpierre M: A Rapid Method for the Purification of DNA From Blood. Nucleic Acids Res 15(22):9611. 11-25-1987
16. Viggiano D, Grammatikopoulos G, Sadile AG: A Morphometric Evidence for a Hyperfunctioning Mesolimbic System in an Animal Model of ADHD. Behav Brain Res 130(1-2):181-9. 3-10-2002
17. Watanabe Y, Fujita M, Ito Y, Okada T, Kusuoka H, Nishimura T: Brain Dopamine Transporter in Spontaneously Hypertensive Rats. J Nucl Med 1997, 38(3):470-4.
18. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ: Dopamine Transporter Density in Patients With Attention Deficit Hyperactivity Disorder. Lancet 354(9196):2132-3. 12-18-1999
19. Dresel S; Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, Hahn K, Tatsch K: Attention Deficit Hyperactivity Disorder: Binding of [99mTc]TRODAT-1 to the Dopamine Transporter Before and After Methylphenidate Treatment. Eur J Nucl Med 2000, 27(10):1518-24.
20. Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH: Lower Dopamine Transporter Binding Potential in Striatum During Depression. Neuroreport 12(18):4121-5. 12-21-2001
21. Madras BK, Miller GM, Fischman AJ: The Dopamine Transporter: Relevance to Attention Deficit Hyperactivity Disorder (ADHD). Behav Brain Res 130(1-2):57-63. 3-10-2002